Agoracom Blog Home

Author Archive

Digital Learning #Edtech: Can it Solve the Access to Education Problem for Indian Students? – SPONSOR: BetterU Education Corp. $BTRU.ca $ARCL $CPLA $BPI $FC.ca

Posted by AGORACOM-JC at 4:20 PM on Wednesday, March 11th, 2020
SPONSOR:  BetterU Education Corp. aims to provide access to quality education from around the world. The company plans to bridge the prevailing gap in the education and job industry and enhance the lives of its prospective learners by developing an integrated ecosystem. Click here for more information.

Digital Learning: Can it Solve the Access to Education Problem for Indian Students?

  • India is home to the largest youth population in the world.
  • As per recent government statistics, we have an estimated 430 million people under the age of 18.

Author: DQINDIA Online

Digital learning can help tackle existing problems in the education sector such as shortage of skilled teachers, lack of adequate teaching materials and so on.

India is home to the largest youth population in the world. As per recent government statistics, we have an estimated 430 million people under the age of 18. These young minds hold immense potential to build a strong future for themselves and the country. A potential that is often held to ransom by an education system marred by outmoded methods of teaching, disproportionate student to teacher ratio, a shortage of skilled teachers and lack of adequate teaching materials.

At a time when technology is transforming every other aspect of our existence, it is only natural that we turn to tech tools to disrupt the way we learn. A lack of access and resources emerges as a constant stumbling block in our youth’s pursuit of education – a problem that can be tackled by modernising the education system through digital learning. Here’s how:

Education beyond Boundaries

Digital content and e-learning can bring entire teaching modules to your doorstep through smart devices, making it possible for students to continue working toward completing their education even if they jump off the path of traditional learning. With a boom in cheaper data and devices, this mode of learning proves especially effective in pursuit of higher education or career-oriented skills. Access to online learning opportunities through remote classes, webinars and online academies can accord equal learning opportunities to students in Tier II and III cities as well as rural areas where skilled educators in one’s desired field of study may not be available.

Personalised Learning

The advent of deep data analytics, Artificial Intelligence and Machine Learning, personalised learning has become a tangible reality. These tech tools allow enable an identification of student goals – whether it is securing merit, landing jobs or simply amassing knowledge – and create educational content to suit these goals. This promotes a truly personalised approach toward learning. With the inclusion of edtech networks and multimedia in education, learning and teaching methods have evolved greatly in their methodology, style and content.

Learning on the Go

Gadgets are an integral part of the youth’s lifestyle today. From shopping to entertainment and social interactions, they seek everything on their finger tips and on the go. Their approach toward education and learning is no exception to this tendency. Digital learning allows them to consume educational content in a format they’re more comfortable in and at a place and setting of their choosing.

Affordability

The cost of higher education in India is steep. By comparison, specialised online course are far more affordable. If you factor in the costs of moving to and living in a big city for students from Tier II and III cities, small towns and rural areas, professional online courses don’t cost a fraction of brick-and-mortar set ups. It is for this reason that India is fast emerging as the second biggest market for MOOCs or open online courses, after the US. This new educational revolution presents great opportunity to help the youth access high-quality education and training, at affordable price points, from the comfort of their homes.

Job Readiness

The higher education in India essentially revolves around securing a stable – ideally, well-paying – job. With easy access to e-learning platforms and digital content, students can access the right kind of content in a format fit for their preferred mode of consumption and be better equipped to meet this goal. For instance, the same curriculum can be easily tweaked to suit academic and competitive purposes in a cost-effective manner in the e-book format.

Future-Ready Education

The world around us is changing at a lightning fast pace, thanks to the constant eruptions of the technology front. Sadly, most of the traditional forums of learning – be it schools, colleges or universities – find themselves lagging behind when it comes to tailoring the course content as per the changing demands of the times we live in. Besides, overhauling entire course curriculums can often a slow, time-consuming process. In such a scenario, professionally tailored online courses can be a bankable alternative in amassing skills training that contributes to employability and is in line with the learners’ interests.

It is undisputable that the future of education will be defined by digital content and learning. Students in India can ride this wave to tide over the inherent flaws in our education system and set themselves up for success in their chosen profession.

Source: https://www.dqindia.com/digital-learning-can-solve-access-education-problem-indian-students/

North Bud Farms $NBUD.ca Launches its NORTHBUD Branded Products in Nevada, USA $CGC $ACB $APH $CRON.ca $OGI.ca

Posted by AGORACOM-JC at 9:11 AM on Wednesday, March 11th, 2020
  • Announced the launch of its NORTHBUD branded products into select retailers in Nevada, USA. 
  • The products are manufactured through NORTHBUD’s ownership and operating agreement with Nevada Botanical Sciences, Inc., who is licensed for cultivation, manufacturing and distribution
  • NORTHBUD products will be available in both dried flower and pre-roll formats under the NORTHBUD White, Black and Platinum brands.

TORONTO, March 11, 2020 – North Bud Farms Inc. (CSE: NBUD) (OTCQB: NOBDF) (“NORTHBUD” or the “Company“) is pleased to announce the launch of its NORTHBUD branded products into select retailers in Nevada, USA.  The products are manufactured through NORTHBUD’s ownership and operating agreement with Nevada Botanical Sciences, Inc. (“NBS”), who is licensed for cultivation, manufacturing and distribution.

NORTHBUD Nevada Launch Strategy Update
Prior to its asset purchase transaction with NORTHBUD, previously announced on November 19, 2019, NBS had been exclusively servicing white label customers.  Over the past 3.5 months, NBS and NORTHBUD have transitioned the Nevada operations to focus on NORTHBUD branded flower products, culminating with the recent launch of NORTHBUD Black 9 Lbs Hammer (Jinxproof phenotype) in 1 gram, 3.5 gram and 7 gram formats to select retailers in Reno, Nevada.

Over the coming weeks, the Company intends to expand distribution to multiple retailers in Northern Nevada and Las Vegas. NORTHBUD products will be available in both dried flower and pre-roll formats under the NORTHBUD White, Black and Platinum brands.

With over 45 million visitors a year from all over the world, Nevada is a key market for building an internationally recognized brand, and the Company believes that it is the ideal market for the launch of its NORTHBUD products. The Nevada market is considered one of the largest and most profitable in North America with recreational sales of USD$580 million in the first full year of legalization (2017 Nevada Dept. of Taxation).

“The NORTHBUD and Bonfire Brands USA team are extremely proud to have launched our own branded products, making the state of Nevada our strategic entry point into the U.S. legal cannabis market,” said Sean Homuth, CEO of NORTHBUD. “We believe the NORTHBUD brand will offer a unique variety of products curated for experienced consumers who demand appropriately priced, high-quality cannabis flower.”

About North Bud Farms Inc.
NORTHBUD, through its U.S. subsidiary Bonfire Brands USA, has acquired cannabis production facilities in California and Nevada. The Salinas, California 11-acre farm is actively cultivating cannabis in its 60,000 sq. ft. of licensed greenhouse production space, and also has active distribution and processing licenses. The Reno, Nevada property contains a world-class cannabis production, research and development facility with 5,000 sq. ft. of indoor cultivation, and holds medical and adult-use licenses for cultivation, extraction and distribution.  Through its wholly-owned Canadian subsidiary, GrowPros MMP Inc., the Company is pursuing a license under The Cannabis Act, to cultivate in its state-of-the-art purpose-built cannabis production facility located on 135 acres of agricultural land in Low, Quebec, Canada.

For more information visit: www.northbud.com

Neither the CSE nor its Regulation Services Provider (as that term is defined in the policies of the CSE) accepts responsibility for the adequacy or accuracy of this release.

Forward-looking statements
Certain statements and information included in this press release that, to the extent they are not historical fact, constitute forward-looking information or statements (collectively, “forward-looking statements”) within the meaning of applicable securities legislation.  Forward-looking statements, include but are not limited to those identified by the expressions “anticipate”, “believe”, “plan”, “estimate”, “expect”, “intend”, “may”, “should” and similar expressions to the extent they relate to the Company or its management.

Forward-looking statements, including but not limited to, those regarding the Company’s Nevada strategy, the success of the Company’s licence application with Health Canada, the Company’s ability to execute its strategic plan, conditions in the cannabis market, the Company entering agreements in connection with the B2B supply of cannabis and the Company’s transition into a revenue-generating operational phase of development are based on the reasonable assumptions, estimates, analysis and opinions of management made in light of its experience and its perception of trends, current conditions and expected developments, as well as other factors that management believes to be relevant and reasonable in the circumstances at the date that such statements are made, but which may prove to be incorrect.

Forward-looking statements involve known and unknown risks, uncertainties and other factors that may cause the actual results, performance or achievements of the Company to differ materially from any future results, performance or achievements expressed or implied by the forward-looking statements.  Such risks and uncertainties include, among others, the risk factors included in the Company’s final long form prospectus dated August 21, 2018, which is available under the Company’s SEDAR profile at www.sedar.com. Accordingly, readers should not place undue reliance on any such forward-looking statements. Further, any forward-looking statement speaks only as of the date on which such statement is made. New factors emerge from time to time, and it is not possible for the Company’s management to predict all of such factors and to assess in advance the impact of each such factor on the Company’s business or the extent to which any factor, or combination of factors, may cause actual results to differ materially from those contained in any forward-looking statements. The Company does not undertake any obligation to update any forward-looking statements to reflect information, events, results, circumstances or otherwise after the date hereof or to reflect the occurrence of unanticipated events, except as required by law including securities laws. This news release does not constitute an offer to sell or a solicitation of any offer to buy any securities of the Company.

FOR ADDITIONAL INFORMATION, PLEASE CONTACT:
North Bud Farms Inc.
Edward Miller
VP, IR & Communications
Office: (855) 628-3420 ext. 3
[email protected]

Hollister Biosciences $HOLL.ca Enters Letter of Intent to Acquire Alphamind $WEED.ca $CGC $ACB $APH $CRON.ca $OGI.ca $FAF.ca Brands

Posted by AGORACOM-JC at 7:02 AM on Wednesday, March 11th, 2020
  • Entered into a letter of intent on March 9th, 2020 to acquire Alphamind Brands
  • Company developing legal mushroom based natural health products and conducting R&D in conjunction with accredited universities to develop psilocybin based compounds for drug development
  • All stock purchase price is anticipated to be CDN$ 1,200,000 with such payment to be made in Hollister common stock

VANCOUVER, March 11, 2020 – Hollister Biosciences Inc. (CSE: HOLL, FRANKFURT: HOB, OTC: HSTRF) (the “Company” or “Hollister“) – a diversified cannabis branding company with products in 220 dispensaries throughout California, is pleased to announce that the Company has entered into a letter of intent (the “LOI“) on March 9th, 2020 to acquire Alphamind Brands ( “Alphamind“), a company developing legal mushroom based natural health products and conducting R&D in conjunction with accredited universities to develop psilocybin based compounds for drug development.

The all stock purchase price is anticipated to be CDN$ 1,200,000 with such payment to be made in Hollister common stock. The stock price will be determined based on the greater of the 14-day VWAP (Volume Weighted Average Price) subsequent to announcing the transaction and $0.20.  The acquisition is subject to normal course due diligence. 

“We are very pleased to have entered into an LOI to complete this very exciting acquisition”, shared Carl Saling, Founder and CEO of Hollister Biosciences Inc.  “It is a fundamental value of our company to improve the overall health and performance of our customers through our high-quality products and the health benefits associated with medicinal mushrooms are tremendous.  Not to mention, it is our continual objective to broaden our product scope and Alphamind, with its experienced management team, is a perfect foothold for us in the fast-growing market for medicinal mushrooms and complements our existing cannabis and hemp-based product offering.”

“I think we have found a great partner in Hollister”, shared Robert Birmingham, CEO of Alphamind Brands.  “We have medicinal mushroom based product SKU’s ready to ship and R&D is underway to develop an exciting IP portfolio surrounding psilocybin based pharmaceutical treatments. Being under the Hollister umbrella will allow us to access additional markets and leverage their existing manufacturing and distribution infrastructure and will be a fundamental part of the future growth of our business.”

In association with the arm’s length transaction, Hollister will not be assuming any long-term debt and there is no change in Management, or the Board of Directors of Hollister being contemplated at this time.

About Hollister Biosciences Inc.

Hollister Biosciences Inc. is a diversified cannabis company with multiple, high-quality products now carried in 220 of Indus Holdings (CSE: INDS), Hollister’s exclusive distribution partner’s 600 dispensaries. This level of penetration is expected to grow as the Company accelerates its seed to shelf, high margin business and product development model.

Capitalizing on this success, Hollister’s vision is to become the sought-after premium brand portfolio of innovative, high quality cannabis across multiple states and hemp products nationwide.

Our wholly owned California subsidiary, Hollister Cannabis Co, is the 1st state and locally licensed Cannabis Company in the City of Hollister, California, the birthplace of the “American Biker” from which we embrace the outlaw roots of Hollister to drive our Company fearlessly down the road of success.

Products from Hollister Cannabis Co. include HashBone, the brand’s premier artisanal hash-infused pre-roll ranked as California’s #1 hash infused pre-roll, along with solvent-free bubble hash, pre-packaged flower, pre-rolls, tinctures, vape products, and full-spectrum high CBD pet tinctures.

Website: www.hollistercannabisco.com 

About Alphamind Brands

Alphamind Brands is a Canada and US based growth stage company developing a portfolio of legal mushroom based natural health products as well as conducting R&D initiatives, led by Dr. Nikos Apostolopoulos, to explore psilocybin based pharmaceutical treatments.  The company’s “ready to ship” product SKU’s include cordyceps, lion’s mane, chaga and reishi mushroom based: liquid cordyceps, concentrated mushroom powder, tea, chocolate.  The company’s product SKU’s under development include syrups, elixirs, cold beverages and nasal spray.

Neither the Canadian Securities Exchange nor its Market Regulator (as that term is defined in the policies of the Canadian Securities Exchange) accepts responsibility for the adequacy or accuracy of this release.

Forward-Looking Information: This news release includes certain statements that may be deemed “forward-looking statements”. The use of any of the words “anticipate”, “continue”, “estimate”, “expect”, “may”, “will”, “would”, “project”, “should”, “believe” and similar expressions are intended to identify forward-looking statements. Although the Company believes that the expectations and assumptions on which the forward-looking statements are based are reasonable, undue reliance should not be placed on the forward-looking statements because the Company can give no assurance that they will prove to be correct. Since forward-looking statements address future events and conditions, by their very nature they involve inherent risks and uncertainties. These statements speak only as of the date of this News Release. Actual results could differ materially from those currently anticipated due to a number of factors and risks including various risk factors discussed in the Company’s disclosure documents which can be found under the Company’s profile on www.sedar.com

View original content to download multimedia:http://www.prnewswire.com/news-releases/hollister-biosciences-enters-letter-of-intent-to-acquire-alphamind-brands-301021154.html

SOURCE Hollister Biosciences Inc.

Tartisan Nickel Corp. $TN.ca Completes Spectral Analysis and SAR Surveys over Sill Lake Lead-Silver Project and Files Assessment Report $ROX.ca $FF.ca $EDG.ca $AGL.ca $ANZ.ca

Posted by AGORACOM-JC at 12:07 PM on Tuesday, March 10th, 2020
Tc logo in black
  • Completed a Spectral Analysis survey and a Synthetic Aperture Radar survey over the Sill Lake Lead-Silver Project, Vankoughnet Township, Ontario
  • The surveys covered all 22 single-cell mining claims as well as the four boundary-cell mining claims owned by the Company’s subsidiary, Canadian Arrow Mines Limited

TORONTO, ON / March 10, 2020 / Tartisan Nickel Corp. (CSE:TN)(OTC:TTSRF)(FSE:A2D) (“Tartisan”, or the “Company”) is pleased to announce that the Company has completed a Spectral Analysis survey and a Synthetic Aperture Radar survey over the Sill Lake Lead-Silver Project, Vankoughnet Township, Ontario. The surveys covered all 22 single-cell mining claims as well as the four boundary-cell mining claims owned by the Company’s subsidiary, Canadian Arrow Mines Limited.

The most abundant minerals on the Sill Lake mining claims were seen to be saponite, a clay mineral from hydrothermal alteration as well as orthoclase feldspar and kaolinite, the hydrothermal alteration product of orthoclase. Principal minerals characteristic of the lead-silver vein were determined to be galena and goethite. Galena is the principal ore mineral of the low-alpha lead on the Sill Lake Project, which goethite is the principal alteration product of sulphides like galena.

As the report notes, “In the centre of the Sill Lake Claims the lead-silver deposit and underground workings are located. The spectral analysis survey outlined a number of minerals spatially associated with the deposit. Using the Target Vector Mineral (“TVM”) overlap technique for the Sill lake Claims a number of areas of where three and four TVM’s overlaps were outlined. One area on the claims outlined a general north-south TVM lead-silver target zone from 65m to 190m wide and approximately 650m in length.”

The anomaly covers the northern trace of the mineralization and is centred on boundary cell mining claim 272137 and single-cell mining claim 297898, with a minor response on claim 206180. Another minor response on claim 204833, when plotted with the others, may suggest a separate structure oriented perpendicular to the principal trend of the Sill Lake lead-silver vein; and along the principal lithological contact between ultramafic intrusive rocks on the north and mafic volcanic rocks to the south, with conformable interbedded sedimentary rocks.

Tartisan CEO Mr. Mark Appleby said, “The survey showed us that there may be much more to the Sill Lake Lead-Silver Project than anyone previously thought. We plan to follow up the anomalies with detailed geological mapping and sampling this summer.”

The Company is pleased with the results of the survey and has requested Aster Funds Ltd to survey and report on the Kenbridge Nickel-Copper-Cobalt Project as well.

About Tartisan Nickel Corp.

Tartisan Nickel Corp. is a Canadian based mineral exploration and development company which owns a 100% stake in the Kenbridge Nickel-Copper Project in Ontario; a 100% interest in the Sill Lake Lead-Silver project, Vankoughnet Township, Ontario; a 100% interest in the Don Pancho Zinc-Lead-Silver Project in Peru just 9 km from Trevali’s Santander mine. Tartisan also owns a 100% stake in the Ichuna Copper-Silver Project, also in Peru, contiguous to Buenaventura’s San Gabriel property. The Company also owns a significant equity stake in Eloro Resources Ltd, which is exploring the low-sulphidation epithermal La Victoria Gold/Silver Project in Ancash, Peru as well as its recently acquired Iska Iska property in Bolivia.

Tartisan Nickel Corp. common shares are listed on the Canadian Securities Exchange (CSE:TN; US-OTC:TTSRF; FSE:A2D). Currently, there are 100,403,550 shares outstanding (103,103 ,550 fully diluted).

For further information, please contact Mr. D. Mark Appleby, President & CEO and a Director of the Company, at 416-804-0280 ([email protected]). Additional information about Tartisan can be found at the Company’s website at www.tartisannickel.com or on SEDAR at www.sedar.com.

Jim Steel MBA P.Geo. is the Qualified Person under NI 43-101 and has read and approved the technical content of this News Release.

This news release may contain forward-looking statements including but not limited to comments regarding the timing and content of upcoming work programs, geological interpretations, receipt of property titles, potential mineral recovery processes, etc. Forward-looking statements address future events and conditions and therefore, involve inherent risks and uncertainties. Actual results may differ materially from those currently anticipated in such statements.

The Canadian Securities Exchange (operated by CNSX Markets Inc.) has neither approved nor disapproved of the contents of this press release.

SOURCE: Tartisan Nickel Corp.

NORTHBUD $NBUD.ca – Legal #pot industry more than doubles contribution to Canada’s #GDP since #legalization: StatsCan $CGC $ACB $APH $CRON.ca $OGI.ca

Posted by AGORACOM-JC at 4:32 PM on Monday, March 9th, 2020

SPONSOR: NORTHBUD (NBUD:CSE) Sustainable low cost, high quality cannabinoid production and procurement focusing on both bio-pharmaceutical development and Cannabinoid Infused Products. Learn More.

Legal pot industry more than doubles contribution to Canada’s GDP since legalization: StatsCan

  • Canada’s cannabis industry represented $7.24 billion to the country’s gross domestic product in December
  • Illicit cannabis market’s contribution to Canada’s GDP has fallen by over 20 per cent

The country’s legal cannabis market represents $3.0 billion of economic output to Canada’s GDP, an increase of 138 per cent when recreational pot was legalized in Oct. 2018. Meanwhile, the illicit cannabis market’s contribution to Canada’s GDP has fallen by over 20 per cent to about $4.18 billion in that same time.

Source: https://www.bnnbloomberg.ca/cannabis-canada-pot-industry-added-nearly-7-24b-to-gdp-in-august-statscan-says-1.1397728

Healthcare IT #Mhealth Market Worth $511.06 Billion by 2027 SPONSOR: CardioComm Solutions $EKG.ca – $ATE.ca $TLT.ca $OGI.ca $ACST.ca $IPA.ca

Posted by AGORACOM-JC at 1:15 PM on Monday, March 9th, 2020

SPONSOR: CardioComm Solutions (EKG: TSX-V) – The heartbeat of cardiovascular medicine and telemedicine. Patented systems enable medical professionals, patients, and other healthcare professionals, clinics, hospitals and call centres to access and manage patient information in a secure and reliable environment.

Healthcare IT Market Worth $511.06 Billion by 2027

  • Healthcare IT market is expected to grow at a CAGR of 13.8% from 2019 to reach $511.06 billion by 2027.

London, March 06, 2020 – According to a new market research report “Healthcare IT Market by Product (EMR, mHealth, PHM, RIS, PACS, RCM, Healthcare Analytics, Telehealth, SCM, HIE), Component (Software, Service), Delivery Mode (Web, Cloud) and End User (Hospital, Payer, Pharmacy, Ambulatory, Homecare)- Global Forecast to 2027”, published by Meticulous Research®, the healthcare IT market is expected to grow at a CAGR of 13.8% from 2019 to reach $511.06 billion by 2027.

Health Information Technology (Healthcare IT) is a broad term that defines the technology and infrastructure utilized to record, analyze, and share patient health data in healthcare organizations. The aim of Healthcare IT solutions is to offer better care for patients and help accomplish health equity. It also endorses recording of patient data to improve healthcare delivery and allow for analysis of information for both healthcare practitioners and ministry of health/government agencies.

With increasing pressure to curtail healthcare cost and improve healthcare quality, investments in healthcare IT are gaining traction and are largely driven by the need for savings, economies of scale, and improving cash flow. According to a survey performed by Octopus group, more than 100 global institutional investors have planned to increase their investment in healthcare infrastructure, including health IT, by $200 billion over the next five years. By adopting various healthcare IT solutions such as EHR, PACS, and CPOE among others, healthcare organizations have reduced the operational cost and improved savings along with better patient care. For instance, with increasing adoption of Cerner Dynamic Documentation platform, Northern Light Health (U.S.) saved an estimated $1.3 million annually, by increasing provider efficiency, improving satisfaction with their electronic health record, and streamlining the discharge process. Similarly, by adopting Cerner ITWorks, University of Missouri Health Care (U.S.) reduced the organization’s IV obsolescence rate by more than 43% over three months. In addition, the university also adopted Cerner’s revenue cycle management solutions in 2018.

The healthcare IT solutions market study presents historical market data in terms of value (2017, and 2018), estimated current data (2019), and forecasts for 2027 – by product, component, delivery mode, end-user, and geography. The study also evaluates industry competitors and analyzes their market share at the global and regional level.

Based on product type, the healthcare providers solutions segment accounted for the largest share of the healthcare IT market and is slated to grow faster during the forecast period. The large share of this segment is primarily attributed to the factors such as growing focus on patient safety & care, increasing demand for integrated healthcare solutions, rising investments in development of healthcare infrastructure in emerging countries, increasing number of government initiatives & regulatory mandates on implementing eHealth solutions, increasing demand for quality healthcare, and rising awareness about electronic health records (EHRs). In addition, growing geriatric population & related ailments and patient workload on healthcare systems across the globe are also driving adoption of digitization solutions among healthcare providers.

Based on component type, the services segment held the largest share of the overall healthcare IT market. The largest share of this segment is mainly attributed to the increasing need to reduce healthcare costs, shift towards cloud-based services, rising adoption of digital solutions across healthcare organizations, and growing need to reduce administrative overheads of the healthcare industry.

Based on delivery mode, the overall healthcare IT market is segmented into web/cloud based and on-premises. Web & cloud-based solutions accounted for the largest share of the overall healthcare IT solutions market owing to its benefits such as on lower upfront cost, on-demand self-serving deployment model, excessive storage flexibility, and greater security.

Based on the end user, healthcare providers held the largest share of the overall healthcare IT market and is projected to grow at a fastest CAGR during the forecast period. The largest share of this segment is mainly attributed to rising patient volume, growing awareness about electronic health records (EHRs), growing healthcare spending by the countries across globe, and increasing adoption of healthcare IT solutions by healthcare providers.

The report also includes extensive assessment of the product portfolio, geographic analysis, and key strategic developments adopted by leading market participants in the industry over the past 4 years (2016–2019). The healthcare IT solutions market has witnessed number of new product launches, agreements, partnerships & collaborations, expansions, and acquisitions in the recent years. For instance, in October 2019, Cerner collaborated with ResMed (U.S.) to help providers make more informed treatment decisions, control costs, and deliver seamless care across health systems. Similarly, in July 2019, McKesson opened its new distribution center in Puyallup, Washington, U.S. to serve hospitals, health systems, community pharmacies, and national retail pharmacies across the state of Washington.

The key players operating in the global healthcare IT market are McKesson Corporation (U.S.), Optum Health (U.S.), International Business Machine Corporation (IBM) (U.S.), Allscripts Healthcare Solutions, Inc. (U.S.), athenahealth, Inc. (U.S.), Epic Systems Corporation (U.S.), Dell Technologies Inc. (U.S.), GE Healthcare (U.S.), Cerner Corporation (U.S.), Oracle Corporation (U.S.), Cognizant Technology Solutions Corporation (U.S.), Nuance Communications, Inc. (U.S.), eClinicalWorks (U.S.) NextGen Healthcare, Inc. (U.S.), Computer Programs and Systems, Inc. (CPSI) (U.S.), Conifer Health Solutions, LLC. (U.S.), 3M Company (U.S.), Koninklijke Philips N.V. (The Netherlands), and Infor, Inc. (U.S.) among others.

Source: https://www.globenewswire.com/news-release/2020/03/06/1996384/0/en/Healthcare-IT-Market-Worth-511-06-Billion-by-2027-Exclusive-Report-by-Meticulous-Research.html

The new election frontier: #Deepfakes are coming and often target women – SPONSOR: Datametrex AI Limited $DM.ca

Posted by AGORACOM-JC at 12:45 PM on Monday, March 9th, 2020

SPONSOR: Datametrex AI Limited (TSX-V: DM) A revenue generating small cap A.I. company that NATO and Canadian Defence are using to fight fake news & social media threats. The company announced three $1M contacts in Q3-2019. Click here for more info.

The new election frontier: Deepfakes are coming and often target women

By C.J. Moore

  • Deepfake technology has been called a powerful feat in artificial intelligence and machine learning at its best, and unsettling — even sinister — at its worst
  • “Deepfakes could be used to influence elections or incite civil unrest, or as a weapon of psychological warfare,” per the report
  • Also notes that much of deepfake content online “is pornographic, and deepfake pornography disproportionately victimizes women.”

Deepfakes are media — usually videos, audio recordings or photographs — that have been doctored through artificial intelligence (AI) software to fabricate a person’s facial or body movements. They can easily spread by sharing over social media platforms and other websites. 

One well-known example is a video that circulated in August 2019, in which actor Bill Hader does an impersonation of Tom Cruise. The video is edited so Hader’s face morphs into a realistic image of Cruise, giving the impression that it’s the latter talking.

Beyond that, deepfake circulation could be damaging in 2020 and future election cycles. Along with celebrities, government leaders are the most common subjects of deepfakes, according to a February Science and Tech Spotlight from the U.S. Government Accountability Office (GAO).

“Deepfakes could be used to influence elections or incite civil unrest, or as a weapon of psychological warfare,” per the report. It also notes that much of deepfake content online “is pornographic, and deepfake pornography disproportionately victimizes women.”

In 2018, Reddit shut down r/deepfakes, a forum that distributed videos of celebrities whose faces had been superimposed on actors in real pornography. The computer-generated fake pornography was banned because it was “involuntary,” or created without consent. 

Much of the same technology used to make those videos could be used to exploit women running for office, according to a GAO official.

“We can’t speak to intent, but the result is definitely that the majority of these do target women,” said Karen Howard, a director on GAO’s Science, Technology Assessment and Analytics (STAA) team.

Read More: https://www.michiganadvance.com/2020/03/09/the-new-election-frontier-deepfakes-are-coming-and-often-target-women/

For #Edtech startups, it’s raining money – SPONSOR: BetterU Education Corp. $BTRU.ca $ARCL $CPLA $BPI $FC.ca

Posted by AGORACOM-JC at 11:52 AM on Monday, March 9th, 2020
SPONSOR:  BetterU Education Corp. aims to provide access to quality education from around the world. The company plans to bridge the prevailing gap in the education and job industry and enhance the lives of its prospective learners by developing an integrated ecosystem. Click here for more information.

For edtech startups, it’s raining money

Tracxn data reveals that Bengaluru-based companies attracted the lion’s share (about $944 million) of investments in the edtech space in the last one year, the highest across cities in India.

By Debojyoti Ghosh

  • Education-technology or edtech companies have mastered the art of wooing investors.
  • The numbers are telling.
  • In less than three months into the new year, edtech ventures have garnered a whopping $686.32 million in 21 funding rounds, a steep surge from $450 million in 87 rounds in the entire 2019, according to data from analytics firm Tracxn.

The data reveals that Bengaluru-based companies attracted the lion’s share (approximately $944 million) of investments in the edtech space in the last one year, the highest across cities in India.

According to data Fortune India has collected, Mumbai-based startups were next in line: raising $109.3 million during the same period. Startups based in Gurugram raised a total of $33.19 million, coming in third. The data includes funding rounds between January 1, 2019, and February 29, 2020.

This year alone, Bengaluru-headquartered Byju’s raised about $500 million, says Tracxn, at an estimated valuation of close to $8 billion. Last month, smaller crosstown rival Unacademy raised $110 million in a funding round led by Facebook and General Atlantic. At the same time, Bengaluru-based interactive online tutoring platform Vedantu raised $24 million, led by global venture capital firm GGV Capital.

Can this buoyancy be sustained?

In the last few years, edtech companies have ramped up their interactive online tutoring content, targeting school students and candidates preparing for competitive examinations and government jobs across metros and tier 2 cities.

RedSeer Consulting, a research and advisory firm focussed on the consumer internet market, noted in its last year’s report that the first wave of edtech companies saw players focussing on high-quality content and live streaming, most often catering to metro/tier 1 users and in English as the major medium of instruction.

“However, our research on learners across market segments (K12, test prep, professional learning) clearly shows a strong need for vernacular education—something which most offline and online platforms fail to provide adequately as of now. Thus, there is a strong underlying need for digital education in vernacular languages,” the RedSeer report said.

Players such as Gurugram-based Doubtnut target students in smaller cities providing learning content in vernacular languages. In January, Doubtnut raised $15 million in a Series A funding round, led by Chinese investor Tencent. Existing investors Omidyar Network India, AET, Japan, Cure.fit co-founder Ankit Nagori, and Sequoia Capital India also participated in the funding round.

Online learning platform Adda247—which provides live video classes, on-demand video courses, mock tests and test prep focussing on examinations for government jobs—also caters to the vernacular segments, particularly the Hindi-speaking belt.

“Across the K12 and professional learning space, players with video lectures have been tailoring to blend English and Hindi in their delivery to drive customer engagement,” RedSeer said.

Other funding announcements this year for edtech startups include Testbook, which in January raised about $8.3 million in a Series B round led by venture capital fund Iron Pillar. The Mumbai-based online preparatory platform provides learning content and test prep for competitive government examinations. Noida-based edtech startup Classplus raised $2.5 million in a pre-Series A funding round from Blume Ventures, Sequoia Capital and others.

With funding available across the various stages of growth, only time will tell if edtech companies can maintain the momentum for the rest of the year.

Source: https://www.fortuneindia.com/bengaluru-buzz/for-edtech-startups-its-raining-money/104233

Hollister Biosciences $HOLL.ca Signs Definitive Agreement to Acquire Venom Extracts With $16.4 Million in Revenue and $2.48 Million EBITDA $WEED.ca $CGC $ACB $APH $CRON.ca $OGI.ca $FAF.ca

Posted by AGORACOM-JC at 4:48 PM on Friday, March 6th, 2020
  • This highly accretive acquisition will strengthen Hollister’s brand portfolio and broaden its distribution across multiple states
  • For the year ended December 31, 2019, Venom Extracts reports having generated CDN$ 16.4 million in revenue and CDN$ 2.48 million in EBIDTA from its product line of Cannabis Concentrates, P.H.O Concentrates and Cartridges.

VANCOUVER, March 6, 2020 – Hollister Biosciences Inc. (CSE: HOLL, FRANKFURT: HOB, OTC: HSTRF) (the “Company” or “Hollister“) – a diversified cannabis branding company with products in 220 dispensaries throughout California, is pleased to announce the Company has entered into a definitive agreement  (the “Agreement“) on March 6th, 2020 to acquire Venom Extracts ( “Venom“), one of Arizona’s premier extract brands and one of the state’s largest producers of award-winning medical cannabis distillate and related products.

On February 25, 2020, the Company first announced a Letter of Intent to acquire Venom, including the following financial figures and terms.

HIGHLY ACCRETIVE $20,000,000 ACQUISITION

For the year ended December 31, 2019, Venom Extracts reports having generated CDN$ 16.4 million in revenue and CDN$ 2.48 million in EBIDTA from its product line of Cannabis Concentrates, P.H.O Concentrates and Cartridges. 2019 Revenue and EBITDA for Venom Extracts are as reported by Management. Though Hollister believes the figures to be highly reliable, their audit will be part of the ongoing due diligence before closing.   

The all stock purchase price is anticipated to be CDN$ 20,000,000, with 70% to be paid upfront and 30% to be paid upon milestone achievements related to revenue targets for Venom. The acquisition is expected to close by March 31, 2020 subject to normal course due diligence.

KEY TERMS OF THE AGREEMENT:

  • The Company will acquire Venom Extracts for CDN$20,000,000 with such payment to be issued in Hollister common stock (the “Payment Shares“)
  • The stock price will be determined based on the greater of:
    • The 14-day VWAP (Volume Weighted Average Price) capped at $0.25 subsequent to announcing the transaction and $0.20
  • Once the share price is established, 70% of the Payment Shares will be issued upon closing of the transaction, subject to hold periods
  • The remaining 30% of the Payment Shares will be issued when and if the following milestones have been met on or prior to December 31st, 2021:
    • 20% (of the total number of Payment Shares) will be issued when revenue of Venom Extracts reaches CDN$ 30,000,000 (calculated in accordance with IFRS from January 1, 2020).
    • 10% (of the total number of Payment Shares) will be issued when revenue of Venom Extracts reaches CDN$ 40,000,000(calculated in accordance with IFRS from January 1, 2020).

“We are very pleased to have entered into a definitive agreement to complete this transformational acquisition”, shared Carl Saling, Founder and CEO of Hollister Biosciences, Inc.  “Financially, we are bolting on substantial revenue and EBITDA, while strategically, this allows for the opportunity to bring Venom into the California marketplace and help scale Hollister’s existing operation. Likewise, it allows for the opportunity to introduce Hollister’s products into the Arizona and Nevada marketplaces to start with.” 

“This is an exciting acquisition and we are happy to be taking this critical step toward closing”, shared Jacob Cohen, Founder of Venom Extracts.  “This transaction represents the next step in ensuring the future growth of both Hollister and Venom.  We are looking forward to increasing the geographic scope of our operation by expanding into the California marketplace through Hollister’s existing platform, as well as, exploring expansion of our existing product scope collectively.”

In association with the acquisition, Hollister will not be assuming any long-term debt, a new control position will be created and there is no change in Management, or the Board of Directors of Hollister being contemplated at this time.

Finder’s fees will be payable in accordance with the policies of the Canadian Securities Exchange.

This press release is available on the Company’s CEO Verified Discussion Forum, a moderated social media platform that enables civilized discussion and Q&A between Management and Shareholders.

About Hollister Biosciences Inc.

Hollister Biosciences Inc. is a diversified cannabis company with multiple, high-quality products now carried in 220 of Indus Holdings (CSE: INDS), Hollister’s exclusive distribution partner’s 600 dispensaries. This level of penetration is expected to grow as the Company accelerates its seed to shelf, high margin business and product development model.

Capitalizing on this success, Hollister’s vision is to become the sought-after premium brand portfolio of innovative, high quality cannabis across multiple states and hemp products nationwide.

Our wholly owned California subsidiary, Hollister Cannabis Co, is the 1st state and locally licensed Cannabis Company in the City of Hollister, California, the birthplace of the “American Biker” from which we embrace the outlaw roots of Hollister to drive our Company fearlessly down the road of success.

Products from Hollister Cannabis Co. include HashBone, the brand’s premier artisanal hash-infused pre-roll ranked as California’s #1 hash infused pre-roll, along with solvent-free bubble hash, pre-packaged flower, pre-rolls, tinctures, vape products, and full-spectrum high CBD pet tinctures.

Website:  www.hollistercannabisco.com 

About Venom Extracts

Venom Extracts is one of Arizona’s premier extract brands and one of the state’s largest producers of award-winning medical cannabis distillate and related products.  With an experienced management team and unparalleled reputation for quality, Venom Extracts prides itself as a differentiated extraction company by producing legal Marijuana products at a price point that allows retailers to generate higher profits.  Focused on proprietary efficiencies, the Company is able to produce more product per square foot than its competition, maintaining lower costs and risks than a typical extraction company. The company’s expansion strategy is centered on entering new markets/states that are approved for medical cannabis use and/or approved or have a reasonable expectation to be approved for recreational use in the near future.  

Website:  www.venomextracts.com

Neither the Canadian Securities Exchange nor its Market Regulator (as that term is defined in the policies of the Canadian Securities Exchange) accepts responsibility for the adequacy or accuracy of this release.

Forward-Looking Information: This news release includes certain statements that may be deemed “forward-looking statements”. The use of any of the words “anticipate”, “continue”, “estimate”, “expect”, “may”, “will”, “would”, “project”, “should”, “believe” and similar expressions are intended to identify forward-looking statements. Although the Company believes that the expectations and assumptions on which the forward-looking statements are based are reasonable, undue reliance should not be placed on the forward-looking statements because the Company can give no assurance that they will prove to be correct. Since forward-looking statements address future events and conditions, by their very nature they involve inherent risks and uncertainties. These statements speak only as of the date of this News Release. Actual results could differ materially from those currently anticipated due to a number of factors and risks including various risk factors discussed in the Company’s disclosure documents which can be found under the Company’s profile onwww.sedar.com.

View original content to download multimedia:http://www.prnewswire.com/news-releases/hollister-biosciences-signs-definitive-agreement-to-acquire-venom-extracts-with-16-4-million-in-revenue-and-2-48-million-ebitda-301019220.html

SOURCE Hollister Biosciences Inc.

#Palladium, #rhodium demand to remain, despite #virus outbreak SPONSOR: New Age Metals $NAM.ca $WG.ca $XTM.ca $WM.ca $PDL.ca $GLEN

Posted by AGORACOM-JC at 5:40 PM on Thursday, March 5th, 2020

SPONSOR: New Age Metals Inc. The company owns one of North America’s largest primary platinum group metals deposit in Sudbury, Canada. Updated NI 43-101 Mineral Resource Estimate 2,867,000 PdEq Measured and Indicated Ounces, with an additional 1,059,000 PdEq Ounces Inferred. Learn More.

Palladium, rhodium demand to remain, despite virus outbreak: analyst

  • Though the coronavirus outbreak may affect near-term automobile demand, long-term demand for palladium and rhodium will remain unchanged

By: Nick Jonson

Washington — Though the coronavirus outbreak may affect near-term automobile demand, long-term demand for palladium and rhodium will remain unchanged unless automakers substitute for other metals, managing director Frederic Panizzutti of MKS Dubai said.

“If I was a carmaker, I would definitely stock palladium while the price is lower, and I believe this is going to keep palladium strong, even if the demand goes down in China, the UK, or the demand for parts decreases,” Panizzutti said in an interview this week.

Rhodium and palladium, along with platinum, are used in automobile catalytic converters to control emissions of certain greenhouse gases and pollutants.

“It’s a bargain for car manufacturers to be able to acquire palladium if it goes lower; it’s been a one-way street for months now,” Panizzutti said, referring to the recent rallies in palladium and rhodium.

NYMEX palladium has risen nearly 25% since the start of the year to reach an intraday high of $2,789.80/oz on February 27. NYMEX palladium for June delivery closed at $2,469.40/oz on Thursday.

Rhodium, which is not traded on major exchanges, has risen nearly 114% since the start of the year. The Platts New York Dealer rhodium price was assessed at $12,700-$13,000/oz on February 27.

Analysts have attributed the sharp price increase to automakers trying to secure enough metal for catalytic converters that meet new emissions standards in China, India and Europe, as well as the US and UK.

Further spread of the coronavirus outbreak globally could reduce automobile demand, along with the projected 1 million oz supply deficit in palladium, Panizzutti said.

The China Passenger Car Association on Wednesday said new car sales in China had plummeted 80% in February from a year ago, the biggest monthly decline on record, though it declined to provide a figure.

Analysts attributed the declining sales to government restrictions to limit the spread of the coronavirus in China, where it began in Hubei Province. Hubei is a major auto manufacturing hub in China.

But even if the coronavirus outbreak becomes a global pandemic, governments and businesses will have to adapt as they do nearly every year with widespread influenza outbreaks, Panizzutti said.

Automobile production, and by extension palladium and rhodium demand, would continue, though possibly at a lower rate, he added.

PLATINUM SUBSTITUTION

“I believe the palladium price now is far over the threshold that automakers are willing to accept,” Panizzutti said.

But substituting platinum for palladium in catalytic converters takes time due to design and testing procedures, he noted.

“In my opinion, it should happen, whether it takes several months or longer because the palladium situation is unsustainable. And I see no reason why the situation should change if nothing changes in the supply/demand balance,” Panizzutti said.

“And the only way to change the supply/demand balance is to switch partially or totally from palladium to platinum. If there is no switch, the situation will be the same and will remain a struggle for manufacturers to get hold of material,” he said.

Source: https://www.spglobal.com/platts/en/market-insights/latest-news/metals/030520-palladium-rhodium-demand-to-remain-despite-virus-outbreak-analyst